As a result of participating in this course, to what extent do you agree that you will be better able to accomplish these objectives * Scoring Key: 5=Strongly Agree 4=Agree 3=Neutral 2=Disagree 1=Strongly Disagree 0=Not applicable to my practice 543210 Analyze clinical studies of non-vitamin K antagonist oral anticoagulants (NOACs) and their impact on prevention and treatment of venous thromboembolism (VTE). Analyze clinical studies of non-vitamin K antagonist oral anticoagulants (NOACs) and their impact on prevention and treatment of venous thromboembolism (VTE). - 5 Analyze clinical studies of non-vitamin K antagonist oral anticoagulants (NOACs) and their impact on prevention and treatment of venous thromboembolism (VTE). - 4 Analyze clinical studies of non-vitamin K antagonist oral anticoagulants (NOACs) and their impact on prevention and treatment of venous thromboembolism (VTE). - 3 Analyze clinical studies of non-vitamin K antagonist oral anticoagulants (NOACs) and their impact on prevention and treatment of venous thromboembolism (VTE). - 2 Analyze clinical studies of non-vitamin K antagonist oral anticoagulants (NOACs) and their impact on prevention and treatment of venous thromboembolism (VTE). - 1 Analyze clinical studies of non-vitamin K antagonist oral anticoagulants (NOACs) and their impact on prevention and treatment of venous thromboembolism (VTE). - 0 Differentiate Phase III clinical trials and Post-authorization Studies of NOACs. Differentiate Phase III clinical trials and Post-authorization Studies of NOACs. - 5 Differentiate Phase III clinical trials and Post-authorization Studies of NOACs. - 4 Differentiate Phase III clinical trials and Post-authorization Studies of NOACs. - 3 Differentiate Phase III clinical trials and Post-authorization Studies of NOACs. - 2 Differentiate Phase III clinical trials and Post-authorization Studies of NOACs. - 1 Differentiate Phase III clinical trials and Post-authorization Studies of NOACs. - 0 Implement strategies for the proper management and reversal of NOACs. Implement strategies for the proper management and reversal of NOACs. - 5 Implement strategies for the proper management and reversal of NOACs. - 4 Implement strategies for the proper management and reversal of NOACs. - 3 Implement strategies for the proper management and reversal of NOACs. - 2 Implement strategies for the proper management and reversal of NOACs. - 1 Implement strategies for the proper management and reversal of NOACs. - 0 Rate the following * Scoring Key: 5=Excellent 4=Very Good 3=Good 2=Fair 1=Poor 54321 Course content. Course content. - 5 Course content. - 4 Course content. - 3 Course content. - 2 Course content. - 1 Alexander G. G. Turpie, M.D., FRCP, FACP, FACC, FRCPC Alexander G. G. Turpie, M.D., FRCP, FACP, FACC, FRCPC - 5 Alexander G. G. Turpie, M.D., FRCP, FACP, FACC, FRCPC - 4 Alexander G. G. Turpie, M.D., FRCP, FACP, FACC, FRCPC - 3 Alexander G. G. Turpie, M.D., FRCP, FACP, FACC, FRCPC - 2 Alexander G. G. Turpie, M.D., FRCP, FACP, FACC, FRCPC - 1 Was this course fair, balanced and without commercial bias? * Yes No If you checked "No,” please explain why: * How many patients will you see in your practice who will likely be impacted by what you learned at this activity? * 1-5 6-10 Over 10 Not applicable to my practice What do you intend to do differently in the treatment of your patients as a result of what you learned? What new strategies will you apply in your practice of patient care? * If you do not plan to implement any new strategies learned, please list any barriers or obstacles that might keep you from doing so. * List topics related to this lecture that you want to learn more about? Comments Please select one: * M.D., D.O. Ph.D. Psy.D. DPM PA-C ARNP R.N. Pharmacist Respiratory Therapist SW/MFT/MHC Other... Please select one: Other... Name Leave this field blank
